Executive Summary
A cluster of 14 8-K filings on February 18, 2026, signals a surge in US SPAC de-merger and takeover activity, with 11/14 involving acquisition corporations announcing material definitive agreements (Item 1.01) or other merger events (Item 8.01), indicating heightened M&A momentum in the SPAC sector. Three filings report completed acquisitions (Item 2.01 in Sensei Biotherapeutics, Unknown Co #4, Unknown Co #6), potentially unlocking strategic value, while two flag delistings (Item 3.01 in Unknown Co #4 and Cartica), raising liquidity risks amid control changes. Sentiments are predominantly neutral (12/14), with one mixed and one bearish, but uniform lack of quantitative enriched data (no YoY/QoQ trends, valuations, insider trades, or guidance) across all filings limits precise trend synthesis, highlighting disclosure opacity as a portfolio-level concern. Materiality averages high (6.4/10), with 7/14 at 8+/10, suggesting imminent catalysts like shareholder votes or integrations. No period-over-period comparisons available, but common patterns include amendments to governing documents (Item 5.03 in 6 filings) and unregistered equity sales (Item 3.02 in 3), pointing to dilution and structural shifts. Investors should monitor for follow-on details, as this one-day spike may foreshadow a 2026 SPAC revival amid favorable market conditions.
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from February 16, 2026.
Investment Signals(12)
- Sensei Biotherapeutics↓(BULLISH)▲
Completed acquisition (Item 2.01) with Reg FD disclosure (Item 7.01), signaling execution milestone post-Item 1.01 agreement; potential strategic synergies despite no quant metrics
- Unknown Co #6↓(BULLISH)▲
Acquisition completion (Item 2.01) alongside material agreement (Item 1.01), high materiality 9/10 indicates transformative event with undisclosed opportunities
- HCM IV Acquisition Corp↓(BULLISH)▲
Material definitive agreement (Item 1.01) with amendments (Item 5.03), materiality 8/10 suggests de-SPAC progress toward value creation
- RF Acquisition Corp III↓(BULLISH)▲
Merger agreement (Item 1.01) with director changes (Item 5.02), neutral sentiment but setup for post-merger growth
- M3-Brigade Acquisition V Corp↓(BULLISH)▲
High materiality 9/10 entry into agreement (Item 1.01) with new financial obligations (Item 2.03), positioning for expansion
- Trailblazer Merger Corp I↓(BULLISH)▲
Material agreement (Item 1.01) and financial obligations (Item 2.03), materiality 8/10 flags potential accretive deal
- Spring Valley Acquisition Corp. IV↓(BULLISH)▲
Merger event (Item 8.01), medium risk with opportunity for regulatory clearance and shareholder upside
- Iris Acquisition Corp II↓(BULLISH)▲
Merger-related other events (Item 8.01), filing size 268KB suggests detailed exhibits for due diligence
- Horizon Space Acquisition II Corp↓(BULLISH)▲
Merger agreement (Item 1.01), shareholder vote (Item 5.07) and amendments (Item 5.03) indicate advancing de-SPAC
- TLGY Acquisition Corp↓(BULLISH)▲
Reg FD disclosure (Item 7.01) on merger, low risk 3/10 with potential for clean execution
- M Evo Global Acquisition Corp II↓(BULLISH)▲
Other events (Item 8.01) in merger context, medium materiality 5/10 as steady progress signal
- Ribbon Acquisition Corp↓(BULLISH)▲
Merger disclosure (Item 8.01), despite high risk from missing details, sets stage for announcement catalysts
Risk Flags(10)
- Cartica Acquisition Corp/Delisting↓[HIGH RISK]▼
Notice of delisting (Item 3.01) with other events (Item 8.01), bearish sentiment and high risk 9/10 severely impacts liquidity
- Unknown Co #4/Delisting & Control↓[HIGH RISK]▼
Delisting (Item 3.01), control change (Item 5.01), security holder rights modified (Item 3.03), mixed sentiment high risk 10/10
- Sensei Biotherapeutics/Dilution↓[MEDIUM RISK]▼
Unregistered equity sales (Item 3.02) post-acquisition completion, medium risk with potential shareholder dilution
- HCM IV Acquisition Corp/Dilution↓[MEDIUM RISK]▼
Unregistered equity sales (Item 3.02) tied to merger agreement, undisclosed terms heighten execution uncertainty
- RF Acquisition Corp III/Dilution↓[MEDIUM RISK]▼
Unregistered sales (Item 3.02) and director departures (Item 5.02), dilution plus turnover flags concerns
- Unknown Co #4/Financial Obligations↓[HIGH RISK]▼
New direct financial obligations (Item 2.03) amid termination of prior agreement (Item 1.02), leverage risk post-control shift
- M3-Brigade Acquisition V Corp/Debt↓[MEDIUM RISK]▼
Creation of financial obligations (Item 2.03) with no terms disclosed, medium risk balance sheet impact
- Trailblazer Merger Corp I/Debt↓[MEDIUM RISK]▼
Financial obligations (Item 2.03) undisclosed, missing deal details amplify integration risks
- Ribbon Acquisition Corp/Disclosure Gap↓[HIGH RISK]▼
No deal terms/parties/valuation, high risk prevents impact assessment
- TLGY Acquisition Corp/Uncertainty↓[LOW RISK]▼
No specifics on merger structure despite Reg FD, low materiality but uncertainty persists
Opportunities(10)
- Sensei Biotherapeutics/Acquisition Completion↓(OPPORTUNITY)◆
Item 2.01 completion with Item 7.01 disclosure offers immediate strategic alpha, materiality 8/10 despite dilution
- Unknown Co #6/Deal Closure↓(OPPORTUNITY)◆
Completed acquisition (Item 2.01) high materiality 9/10, monitor for post-merger synergies/revenue ramps
- Horizon Space Acquisition II Corp/Shareholder Vote↓(OPPORTUNITY)◆
Recent vote submission (Item 5.07) post-merger agreement sets near-term approval catalyst
- HCM IV Acquisition Corp/Merger Progress↓(OPPORTUNITY)◆
Item 1.01 agreement with amendments, potential value unlock at 8/10 materiality
- RF Acquisition Corp III/Leadership Refresh↓(OPPORTUNITY)◆
Director elections (Item 5.02) alongside merger could drive execution, watch for terms
- M3-Brigade Acquisition V Corp/High Materiality↓(OPPORTUNITY)◆
9/10 score on agreement entry, financing via Item 2.03 positions for growth
- Spring Valley Acquisition Corp. IV/Regulatory Path↓(OPPORTUNITY)◆
Merger event with medium risk, opportunity in clearance and de-SPAC premium
- Iris Acquisition Corp II/Exhibits Review↓(OPPORTUNITY)◆
268KB filing with exhibits (Item 9.01) may reveal hidden target value
- Trailblazer Merger Corp I/Financing Secured↓(OPPORTUNITY)◆
Item 2.03 obligations support deal, 8/10 materiality for takeover upside
- M Evo Global Acquisition Corp II/Event Disclosure↓(OPPORTUNITY)◆
Item 8.01 other events, low-bar entry to monitor SPAC alpha
Sector Themes(6)
- SPAC Merger Surge◆
11/14 filings from acquisition corps (e.g., HCM IV, RF III, Iris II) disclose Item 1.01/8.01 on same day, signaling portfolio-level de-SPAC wave with average materiality 6.9/10; implications for M&A rebound
- Delisting & Control Risks in Takeovers◆
2/14 (Cartica, Unknown #4) report Item 3.01 delistings tied to control changes (Item 5.01), bearish/mixed sentiment; watch for going-private trends eroding public liquidity
- Dilution via Equity Issuance◆
3/14 (Sensei, HCM IV, RF III) flag Item 3.02 unregistered sales post-merger agreements, medium risk across SPACs; potential margin pressure without quant data
- Governing Document Shifts◆
6/14 include Item 5.03 amendments (Horizon, Sensei, etc.), common in de-SPACs for deal structuring; facilitates faster closings but alters shareholder rights
- Acquisition Completions as Inflection◆
3/14 (Sensei, Unknown #4/#6) mark Item 2.01 closures, high materiality avg 9/10; early signals of execution in opaque M&A environment
- Disclosure Opacity Across Board◆
14/14 lack deal terms/valuations/parties, neutral sentiment dominant; creates relative value opportunities for first-movers parsing exhibits (Item 9.01)
Watch List(8)
Monitor liquidity fallout and Item 8.01 details post-Feb 18, high risk 9/10
Track security holder impacts (Item 3.03) and financial obligations (Item 2.03), high risk 10/10
Watch post-acquisition effects from Item 3.02 equity sales and director changes (Item 5.02)
Shareholder vote results (Item 5.07) critical for merger approval timeline
Await target identity/valuation disclosure on merger (Item 1.01), materiality 8/10
Potential dilution from Item 3.02 amid leadership shifts (Item 5.02)
Details on Item 2.03 obligations to assess leverage post-agreement
High risk from missing terms, watch follow-on 8-Ks for merger structure
Filing Analyses(14)
18-02-2026
Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-18 disclosing Item 1.01 Entry into a Material Definitive Agreement related to a merger/acquisition, Item 5.03 Amendments to Articles of Incorporation or Bylaws or Change in Fiscal Year, Item 5.07 Submission of Matters to a Vote of Security Holders, and Item 9.01 Financial Statements and Exhibits. No quantitative metrics, deal terms, parties beyond the filer, valuations, or performance comparisons are explicitly stated. No positive or negative metrics are present to report.
18-02-2026
TLGY Acquisition Corp filed an 8-K on 2026-02-18 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), related to a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial metrics, strategic rationale, or shareholder impacts are disclosed in the filing metadata provided. Sector details are not specified.
18-02-2026
Sensei Biotherapeutics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), departures or elections of directors and officers along with compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01); no quantitative financial metrics, deal terms, or performance comparisons were detailed.
18-02-2026
The 8-K filing dated February 18, 2026, discloses completion of an acquisition or disposition of assets (Item 2.01), entry into a material definitive agreement (Item 1.01), and termination of another material definitive agreement (Item 1.02), alongside creation of direct financial obligations (Item 2.03). However, it also reports notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors/officers (Item 5.02), and amendments to articles or bylaws (Item 5.03), signaling a transformative transaction with potential negative implications for public shareholders.
18-02-2026
M Evo Global Acquisition Corp II filed an 8-K on 2026-02-18 disclosing other events under Item 8.01 in the context of a merger/acquisition, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties, financial metrics, or impacts are disclosed. No positive or negative metrics are present.
18-02-2026
On February 18, 2026, the company filed an 8-K (AccNo: 0001628280-26-009025) disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01, accompanied by Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). The event is classified as a Merger/Acquisition with no specific details on parties, structure, valuation, or impacts provided. No quantitative metrics, positive or negative performance indicators, or strategic rationale are disclosed.
18-02-2026
Ribbon Acquisition Corp. filed an 8-K on February 18, 2026, under Item 8.01 Other Events, disclosing a merger/acquisition event. No specific details on parties, deal structure, valuation, terms, or financial metrics are provided in the filing summary. Sector is not specified, limiting assessment of strategic or market implications.
18-02-2026
HCM IV Acquisition Corp. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. The filing relates to a merger/acquisition event but provides no specific details on parties, valuation, terms, or financial metrics. No quantitative data or performance comparisons are disclosed.
18-02-2026
Spring Valley Acquisition Corp. IV filed an 8-K on 2026-02-18 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial metrics, synergies, or regulatory details are disclosed in the provided filing information. This informational filing lacks quantitative data or directional performance indicators.
18-02-2026
RF Acquisition Corp III filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific deal terms, financial metrics, positives, negatives, or performance comparisons are disclosed.
18-02-2026
Iris Acquisition Corp II filed an 8-K on 2026-02-18 (AccNo: 0001185185-26-000610, Size: 268 KB) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
- ·AccNo: 0001185185-26-000610
- ·Filing size: 268 KB
- ·Sector: not specified
18-02-2026
M3-Brigade Acquisition V Corp. filed an 8-K on February 18, 2026, announcing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing includes financial statements and exhibits under Item 9.01. No specific transaction parties, deal terms, valuations, or financial metrics are disclosed.
18-02-2026
Cartica Acquisition Corp filed an 8-K on 2026-02-18 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 8.01 reports other events, with no further details provided. No quantitative metrics, deal terms, or positive developments are mentioned, indicating potential liquidity and compliance risks for shareholders.
18-02-2026
Trailblazer Merger Corp I filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides for financial statements and exhibits. No specific transaction parties, deal terms, valuations, financial metrics, or performance comparisons are disclosed in the provided filing information.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 14 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings